~~<i id='AC6702A137'><strike id='AC6702A137'><tt id='AC6702A137'><pre id='AC6702A137'></pre></tt></strike></i>~~

Home» focus» Wikipedia

Wikipedia

author：explore 2025-10-06 14:22:44 Page View：38254

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple
Next article： Guidelines to prevent youth baseball injuries need more muscle

Wikipedia

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Trump pressured former Arizona governor to overturn 2020 election results: Sources

2:35FormerPresidentandRepublicanpresidentialcandidateDonaldTrumplooksonasheattendstheNorthCarolinaRe

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

When prostate cancer spreads, where it goes matters

Prostatecancercellsseenunderthemicroscope.NIHProstatecancertendstobethetortoiseoftumors,growingandsp